Our group explores the mechanisms underlying the formation of the human heart. The embryonic heart, the first functional organ to form in humans, develops from endocardial, myocardial and epicardial progenitors. These organ precursors co-develop resulting in self-organization of major cardiac structures. Despite our insights about cardiac development, it remains a major challenge to discern how molecules instruct cells to self-organize into a functional heart, and how this fails in disease.
The most common human birth defects originate from faulty self-organization of mesodermal precursors during cardiogenesis. The resulting congenital heart disorders affect many pregnancies, children and a growing number of adults with life-long complications. Cardiac developmental genes and processes play also an important role in the aetiology of cardiovascular disease - the major cause of death worldwide (32% of all deaths, source: WHO) due to missing treatments. Thus, insights into how mechanisms of cardiogenesis are linked to heart disease will lead to development of much needed treatment strategies.
Human pluripotent stem cell (hPSC) differentiation and derivation of organoids have revolutionised human developmental biology and opened new avenues to regenerative medicine. However, we are still far from mimicking the fascinating complexity of cardiogenesis. While hPSC can be differentiated into multiple cardiac cell types, the key self-organizing processes of heart tube formation, looping, trabeculation, ballooning, septation, valve development and functional maturation remain elusive. Further challenges comprise modeling heart-specific vascularisation, innervation and interactions with adipose tissue, which have a major impact on cardiac development, function and disease.
Our guiding principle is that to understand heart development and disease in patients, we must be able to recreate these linked processes in the lab.
Our aim is to discover how signaling and gene expression drive self-organization and functional maturation of the heart, and how mutations cause disorders of cardiogenesis. Our hypothesis is that organoids need to recapitulate development as faithfully as possible to serve as predictive disease models. Missing human cardiac models that allow development of therapies and predict responses in patients are the biggest bottlenecks towards much needed treatments in cardiovascular disease. Our mission is to address this key problem affecting more patients than any other disease on the planet.
To achieve our objectives, we systematically apply principles of in vivo development and translate them to in vitro models. Our lab philosophy is to tackle this challenge at the molecular, cellular and organ scale. We combine stem cell differentiation into self-organizing organoids, and perturbations by small molecules, CRISPR, and degrons, with quantitative imaging, as well as with global epigenome, transcriptome and proteome analysis.
|2021||Taking Heart Development to the Next Level.||Cell Stem Cell||Jahnel, SM., Mendjan, S.|
|2021||Unraveling the Developmental Roadmap toward Human Brown Adipose Tissue.||Stem Cell Reports||Carobbio, S., Guenantin, AC., Bahri, M., Rodriguez-Fdez, S., Honig, F., Kamzolas, I., Samuelson, I., Long, K., Awad, S., Lukovic, D., Erceg, S., Bassett, A., Mendjan, S., Vallier, L., Rosen, BS., Chiarugi, D., Vidal-Puig, A.|
|2021||In vitro models of the human heart.||Development||Hofbauer, P., Jahnel, SM., Mendjan, S.|
|2021||Comparative proteome signatures of trace samples by multiplexed Data-Independent Acquisition.||Mol Cell Proteomics||Ctortecka, C., Krššáková, G., Stejskal, K., Penninger, JM., Mendjan, S., Mechtler, K., Stadlmann, J.|
|2021||Unraveling the Developmental Roadmap toward Human Brown AdiposeTissue.||Stem Cell Reports||Carobbio, S., Guenantin, AC., Bahri, M., Rodriguez-Fdez, S., Honig, F., Kamzolas, I., Samuelson, I., Long, K., Awad, S., Lukovic, D., Erceg, S., Bassett, A., Mendjan, S., Vallier, L., Rosen, BS., Chiarugi, D., Vidal-Puig, A.|
|2021||Cardioids reveal self-organizing principles of human cardiogenesis.||Cell||Hofbauer, P., Jahnel, SM., Papai, N., Giesshammer, M., Deyett, A., Schmidt, C., Penc, M., Tavernini, K., Grdseloff, N., Meledeth, C., Ginistrelli, LC., Ctortecka, C., Šalic, Š., Novatchkova, M., Mendjan, S.|
|2020||Cardioids reveal self-organizing principles of human cardiogenesis||BioRxiv||Pablo Hofbauer, Stefan Jahnel, Nora Papai, Magdalena Giesshammer, Mirjam Penc, Katherina Tavernini, Nastasja Grdseloff, Christy Meledeth, Alison Deyett, Clara Schmidt, Claudia Ctortecka, Šejla Šalic, Maria Novatchkova, Sasha Mendjan|
|2019||Estrogen Signaling Drives Ciliogenesis in Human Endometrial Organoids.||Endocrinology||Haider, S., Gamperl, M., Burkard, TR., Kunihs, V., Kaindl, U., Junttila, S., Fiala, C., Schmidt, K., Mendjan, S., Knöfler, M., Latos, PA.|
|2018||The SMAD2/3 interactome reveals that TGFβ controls m6A mRNA methylation in pluripotency.||Nature||Bertero, A., Brown, S., Madrigal, P., Osnato, A., Ortmann, D., Yiangou, L., Kadiwala, J., Hubner, NC., de Los Mozos, IR., Sadée, C., Lenaerts, AS., Nakanoh, S., Grandy, R., Farnell, E., Ule, J., Stunnenberg, HG., Mendjan, S., Vallier, L.|
|2018||Self-Renewing Trophoblast Organoids Recapitulate the Developmental Program of the Early Human Placenta.||Stem Cell Reports||Haider, S., Meinhardt, G., Saleh, L., Kunihs, V., Gamperl, M., Kaindl, U., Ellinger, A., Burkard, TR., Fiala, C., Pollheimer, J., Mendjan, S., Latos, PA., Knöfler, M.|
|2015||Activin/nodal signaling and NANOG orchestrate human embryonic stem cell fate decisions by controlling the H3K4me3 chromatin mark.||Genes Dev||Bertero, A., Madrigal, P., Galli, A., Hubner, NC., Moreno, I., Burks, D., Brown, S., Pedersen, RA., Gaffney, D., Mendjan, S., Pauklin, S., Vallier, L.|
|2015||Brachyury and SMAD signalling collaboratively orchestrate distinct mesoderm and endoderm gene regulatory networks in differentiating human embryonic stem cells.||Development||Faial, T., Bernardo, AS., Mendjan, S., Diamanti, E., Ortmann, D., Gentsch, GE., Mascetti, VL., Trotter, MW., Smith, JC., Pedersen, RA.|
|2014||NANOG and CDX2 pattern distinct subtypes of human mesoderm during exit from pluripotency.||Cell Stem Cell||Mendjan, S., Mascetti, VL., Ortmann, D., Ortiz, M., Karjosukarso, DW., Ng, Y., Moreau, T., Pedersen, RA.|
|2012||Synthetic organs for regenerative medicine.||Cell Stem Cell||Pedersen, RA., Mascetti, V., Mendjan, S.|
|2012||Status of genomic imprinting in epigenetically distinct pluripotent stem cells.||Stem Cells||Sun, B., Ito, M., Mendjan, S., Ito, Y., Brons, IG., Murrell, A., Vallier, L., Ferguson-Smith, AC., Pedersen, RA.|
|2009||Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.||Development||Vallier, L., Mendjan, S., Brown, S., Chng, Z., Teo, A., Smithers, LE., Trotter, MW., Cho, CH., Martinez, A., Rugg-Gunn, P., Brons, G., Pedersen, RA.|
|2007||The right dose for every sex.||Chromosoma||Mendjan, S., Akhtar, A.|
|2006||Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila.||Mol Cell||Mendjan, S., Taipale, M., Kind, J., Holz, H., Gebhardt, P., Schelder, M., Vermeulen, M., Buscaino, A., Duncan, K., Mueller, J., Wilm, M., Stunnenberg, HG., Saumweber, H., Akhtar, A.|